Archive for March 9th, 2010

Peptimmune Announces Second Grant Of A United States Patent For PI-2301 Peptide Copolymer For Multiple Sclerosis

9th March
2010
written by Multiple Sclerosis News From Medical News Today

Peptimmune, Inc. a privately held biotechnology company, announced the grant of US Patent Number 7,655,221 (the ’221 patent) which protects the target product profile for its PI-2301 peptide copolymer for the treatment of multiple sclerosis, and other autoimmune diseases. The ’221 patent claims important treatment modalities for PI-2301 and related compounds…

0 Comments
Multiple Sclerosis